Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Benchmark Analyst Recommends Buy Rating for Caseys General Stores with 312 Price Target

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Retail Stock Bull Market
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 6, 2024, analyst John Lawrence from Benchmark has once again recommended a Buy rating for Casey’s General Stores (NASDAQ:CASY) with a price target of $312. Lawrence’s continued confidence in the company’s potential suggests a bullish perspective on its future performance and stock price. ___ Overall, Casey’s General Stores seems poised for success in the market.

Caseys General Stores Inc. (CASY) Shows Strong Performance in Stock Market on March 6, 2024

On March 6, 2024, Casey’s General Stores Inc. (CASY) saw a strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, CASY showed signs of positive momentum.

The stock opened at $294.93, which was $3.65 higher than its previous close. Throughout the trading day, CASY shares continued to rise, ultimately increasing by $11.68, a 4.01% rise from the market’s last close.

This significant price increase indicates that investors have confidence in CASY’s performance and potential for growth. The stock’s strong performance on March 6 reflects positive sentiment surrounding the company and its prospects in the market.

Casey’s General Stores Inc. is a well-known retailer that operates convenience stores across the United States. With a focus on providing quality products and services to its customers, CASY has established a strong presence in the retail industry.

Overall, the positive price momentum and strong performance of CASY on March 6, 2024, indicate that the company may be on track for continued success in the market.

CASY Stock Shows Strong Performance with 16.54% Increase in Total Revenue – March 6, 2024

On March 6, 2024, CASY (Casey’s General Stores Inc.) stock showed strong performance based on the company’s financial data. According to CNN Money, the total revenue for CASY was $15.09 billion for the past year, with a significant increase of 16.54% compared to the previous year. The net income for CASY was $446.69 million for the past year, representing a notable increase of 31.46% compared to the previous year. Earnings per share (EPS) for CASY was $11.91 for the past year, reflecting a strong increase of 30.89% compared to the previous year. Overall, CASY’s financial performance on March 6, 2024, was positive, with strong growth in total revenue and net income compared to the previous year. Investors may view CASY as a promising investment opportunity based on its solid financial performance and growth potential.

Tags: CASY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Boeings Lack of Cooperation Hinders Alaska Airlines Max 9 Investigation

Anticipating Superior Industries Intls Quarterly Earnings and Future Growth

Technology Data analytics stock Trading (1)

Analyzing Palantir Technologiess Financial Performance Among Software Industry Competitors

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com